96 related articles for article (PubMed ID: 12379480)
1. Role of platelet endothelial form of nitric oxide synthase in collagen-platelet interaction: regulation by phosphorylation.
Chiang TM; Woo-Rasberry V; Cole F
Biochim Biophys Acta; 2002 Oct; 1592(2):169-74. PubMed ID: 12379480
[TBL] [Abstract][Full Text] [Related]
2. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets.
Fleming I; Schulz C; Fichtlscherer B; Kemp BE; Fisslthaler B; Busse R
Thromb Haemost; 2003 Nov; 90(5):863-71. PubMed ID: 14597982
[TBL] [Abstract][Full Text] [Related]
3. Vanadate is a potent activator of endothelial nitric-oxide synthase: evidence for the role of the serine/threonine kinase Akt and the 90-kDa heat shock protein.
Papapetropoulos A; Fulton D; Lin MI; Fontana J; McCabe TJ; Zoellner S; García-Cardeña G; Zhou Z; Gratton JP; Sessa WC
Mol Pharmacol; 2004 Feb; 65(2):407-15. PubMed ID: 14742683
[TBL] [Abstract][Full Text] [Related]
4. Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation.
Ozüyaman B; Gödecke A; Küsters S; Kirchhoff E; Scharf RE; Schrader J
Thromb Haemost; 2005 Jun; 93(6):1161-7. PubMed ID: 15968403
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide synthase in collagen-platelet interaction: involvement of platelet nonintegrin collagen receptor nitrotyrosylation.
Chiang TM; Cole F; Woo-Rasberry V; Kang ES
Thromb Res; 2001 May; 102(4):343-52. PubMed ID: 11369427
[TBL] [Abstract][Full Text] [Related]
6. Platelet nitric oxide synthase is activated by tyrosine dephosphorylation: possible role for SHP-1 phosphatase.
Patel B; Sharifi M; Milward AD; Oberprieler NG; Gibbins JM; Parkin S; Naseem KM
J Thromb Haemost; 2006 Nov; 4(11):2423-32. PubMed ID: 16898954
[TBL] [Abstract][Full Text] [Related]
7. Endothelial nitric oxide synthase (eNOS) in platelets: how is it regulated and what is it doing there?
Randriamboavonjy V; Fleming I
Pharmacol Rep; 2005; 57 Suppl():59-65. PubMed ID: 16415487
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of receptor-mediated nitric oxide production by vanadate.
Hellermann GR; Flam BR; Eichler DC; Solomonson LP
Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2045-50. PubMed ID: 10978247
[TBL] [Abstract][Full Text] [Related]
9. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene.
Freedman JE; Sauter R; Battinelli EM; Ault K; Knowles C; Huang PL; Loscalzo J
Circ Res; 1999 Jun; 84(12):1416-21. PubMed ID: 10381894
[TBL] [Abstract][Full Text] [Related]
10. Serine/threonine dephosphorylation may be involved in tyrosine phosphorylation: a new mode of signal transduction in platelets.
Artçanuthurry V; Grelac F; Maclouf J; Martin-Cramer E; Levy-Tolédano S
Semin Thromb Hemost; 1996; 22(4):317-26. PubMed ID: 8944416
[TBL] [Abstract][Full Text] [Related]
11. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.
Russo I; Doronzo G; Mattiello L; De Salve A; Trovati M; Anfossi G
Thromb Res; 2004; 114(4):265-73. PubMed ID: 15381390
[TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone prevents the aggregation of platelets obtained from postmenopausal women with type 2 diabetes mellitus through the activation of the PKC/eNOS/NO pathway.
Muñoz YC; Gomez GI; Moreno M; Solis CL; Valladares LE; Velarde V
Horm Metab Res; 2012 Jul; 44(8):625-31. PubMed ID: 22517552
[TBL] [Abstract][Full Text] [Related]
13. Okadaic acid and vanadate inhibit collagen-induced platelet aggregation; the functional relation of phosphatases on platelet aggregation.
Chiang TM
Thromb Res; 1992 Aug; 67(4):345-54. PubMed ID: 1384163
[TBL] [Abstract][Full Text] [Related]
14. G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells.
Federici M; Pandolfi A; De Filippis EA; Pellegrini G; Menghini R; Lauro D; Cardellini M; Romano M; Sesti G; Lauro R; Consoli A
Circulation; 2004 Jan; 109(3):399-405. PubMed ID: 14707024
[TBL] [Abstract][Full Text] [Related]
15. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S
FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of shear stress-induced endothelial nitric-oxide synthase phosphorylation and expression in ovine fetoplacental artery endothelial cells.
Li Y; Zheng J; Bird IM; Magness RR
Biol Reprod; 2004 Mar; 70(3):785-96. PubMed ID: 14627548
[TBL] [Abstract][Full Text] [Related]
17. Differential eNOS-signalling by platelet subpopulations regulates adhesion and aggregation.
Radziwon-Balicka A; Lesyk G; Back V; Fong T; Loredo-Calderon EL; Dong B; El-Sikhry H; El-Sherbeni AA; El-Kadi A; Ogg S; Siraki A; Seubert JM; Santos-Martinez MJ; Radomski MW; Velazquez-Martinez CA; Winship IR; Jurasz P
Cardiovasc Res; 2017 Dec; 113(14):1719-1731. PubMed ID: 29016749
[TBL] [Abstract][Full Text] [Related]
18. Different isoforms of tocopherols enhance nitric oxide synthase phosphorylation and inhibit human platelet aggregation and lipid peroxidation: implications in therapy with vitamin E.
Li D; Saldeen T; Romeo F; Mehta JL
J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):155-61. PubMed ID: 11509922
[TBL] [Abstract][Full Text] [Related]
19. Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels.
Yemisci M; Ay H; Kocaefe C; Qui J; Topalkara K; Ozgüç M; Kirazli S; Ozcebe O; Moskowitz MA; Dalkara T
Cerebrovasc Dis; 2008; 26(2):190-8. PubMed ID: 18628618
[TBL] [Abstract][Full Text] [Related]
20. eNOS phosphorylation in health and disease.
Kolluru GK; Siamwala JH; Chatterjee S
Biochimie; 2010 Sep; 92(9):1186-98. PubMed ID: 20363286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
